Researchers at the University of Oklahoma are advancing the fight against inherited retinal diseases (IRDs) with new genetic research that aims to improve diagnoses and lay the groundwork for future therapies.

The University of Oklahoma is pleased to announce that Abdul Rafeh Naqash, MD has been awarded a 2025 Conquer Cancer Career Development Award (CDA) by the ASCO Foundation. The award will be presented during the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30–June 3 in Chicago, Illinois.

The University of Oklahoma College of Allied Health celebrated the graduation of its first class of doctoral-level occupational therapy students this month. The OU program is the first accredited occupational therapy doctoral program in the state of Oklahoma. The program, which serves students in Oklahoma City and Tulsa, was recently changed from a master’s program to a doctoral program in order to widen opportunities for graduates in the future.

In medicine, moving a breakthrough from the lab to the doctor’s office often involves navigating a dizzying maze of bureaucratic and financial obstacles. Most health care startups – 90% by some estimates – fail to find a path to profitability. But one Oklahoma City-based company is poised to become an exception. Fourteen years after its founding, Moleculera Biosciences is emerging from the startup labyrinth.

The Univeristy of Oklahoma College of Medicine is pleased to announce the appointment of Irene Alexandraki, M.D., Ph.D., MPH, MBA, FACP, as the Inaugural Vice Dean of Education at the University of Oklahoma College of Medicine, effective July 2025, pending OU Regents’ approval.  Alexandraki will also work closely with the OU School of Community Medicine.